Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aurinia Pharmaceuticals Inc - Common Shares
(NQ:
AUPH
)
14.80
-0.47 (-3.11%)
Streaming Delayed Price
Updated: 1:32 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharmaceuticals Inc - Common Shares
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
AUPH INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation – AUPH
April 05, 2022
From
Rosen Law Firm
Via
Business Wire
Cramer Shares His Thoughts On PubMatic, Aurinia Pharmaceuticals And More
↗
April 05, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said although Kulicke and Soffa Industries, Inc.
Via
Benzinga
Aurinia Pharmaceuticals Announces Presentations at the 2022 National Kidney Foundation Spring Clinical Meetings
April 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
March 16, 2022
From
The Schall Law Firm
Via
Business Wire
Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook
↗
February 28, 2022
The company expects 150%-200% growth in its key product. But that wasn't enough.
Via
Investor's Business Daily
Earnings Scheduled For February 28, 2022
↗
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm
March 15, 2022
From
The Schall Law Firm
Via
Business Wire
AUPH INVESTOR NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Inquire About Securities Class Action Investigation AUPH
March 11, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
↗
March 08, 2022
Over the past 3 months, 4 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:AUPH) stock. These analysts are typically employed by large Wall Street banks...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
March 08, 2022
Raymond James cut the price target on Ciena Corporation (NYSE: CIEN) from $80 to $75. Ciena shares fell 10.9% to close at $58.76 on Monday. Telsey Advisory Group cut Capri...
Via
Benzinga
Expert Ratings For Aurinia Pharmaceuticals
↗
December 10, 2021
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed...
Via
Benzinga
67 Biggest Movers From Yesterday
↗
March 01, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack...
Via
Benzinga
42 Stocks Moving In Monday's Mid-Day Session
↗
February 28, 2022
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group...
Via
Benzinga
Stocks Mixed as Investors Weigh Sanctions
↗
February 28, 2022
U.S. markets have cut a great deal of this morning's losses, though the Dow Jones Industrial Average (DJI) is still down
Via
Talk Markets
Why Aurinia Pharmaceuticals Shares Are Falling Today
↗
February 28, 2022
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is trading significantly lower Monday after the company reported declining fourth-quarter financial results on a year-over-year basis....
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower Amid Ongoing Russia-Ukraine Conflict
↗
February 28, 2022
U.S. stocks opened on a downbeat note this morning, amid the ongoing Russia-Ukraine conflict, which has led to increased US sanctions on Russia. Following the market opening...
Via
Benzinga
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
February 28, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
February 09, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present at the 11th Annual Leerink Global Healthcare Conference
February 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences
January 04, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
↗
December 09, 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of...
Via
Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
↗
December 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
↗
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
December 09, 2021
Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
December 09, 2021
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
61 Biggest Movers From Yesterday
↗
December 03, 2021
Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information...
Via
Benzinga
Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors
↗
December 02, 2021
Aurinia Pharma popped after Novartis said it's focused on bolt-on deals.
Via
Investor's Business Daily
EXPR Stock: 7 Reasons Why Express Investors Are Feeling Giddy Today
↗
December 02, 2021
Investors in Express (EXPR) stock are celebrating on Thursday thanks to the release of the company's Q3 2021 earnings report.
Via
InvestorPlace
BFRI Stock: The News That Has Biofrontera Shares Bounding Higher Today
↗
December 02, 2021
Biofrontera (BFRI) stock is getting a boost on Thursday thanks to an update from the United States Patent and Trademark Office.
Via
InvestorPlace
Topics
Intellectual Property
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
↗
December 02, 2021
Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).
Via
InvestorPlace
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
